Zacks Small Cap Research on MSN

RADX: Interim readout achieves 92% concordance

RADX READ THE FULL RADX RESEARCH REPORT RAD101 Phase IIb Interim Analysis Radiopharm Theranostics (NASDAQ:RADX) reported the primary endpoint for its RAD101 trial in an interim analysis on December ...
ALT shares drop over 20% after updated pemvidutide week 48 data; see FDA's stance on non-invasive fibrosis tests. Click here ...
Pediatric ENT emergencies pose unique risks because small anatomic airways can make minor pathology life-threatening in minutes. The WHO pediatric emergency care framework underscores the urgency of ...
NotebookLM with Gemini v3 now builds slide decks from your notes and preserves citations, so you can share polished ...